RecruitingAccepts healthy volunteers
The Ohio State University Dermatology Biorepository
Ohio State University · NCT03146676
View Study & Apply (opens in a new tab)
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Any age listed · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 175
- US sites recruiting
- 1
- Study start
- April 19, 2017
- Record last updated
- February 27, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This study will create and extend a source of clinical specimens for the future study of inflammatory skin disorders.
Conditions: Hidradenitis Suppurativa
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Seen by an Ohio State University (OSU) Dermatology provider on the main University Hospital campus, including the James Cancer Hospital, OSU Dermatology East, OSU Dermatology at the Ohio State Eye and Ear Institute, Martha Morehouse Medical Pavilion, and OSU Dermatology at Upper Arlington after the date of approval of this protocol
- Ability to provide informed consent, or parent or legal guardian capable of providing consent for child or mentally handicapped individuals
- Willingness to participate in a research study.
Exclusion Criteria
- Inability to provide informed consent
Recruiting US locations
OSU Dermatology West
Columbus, OH 43215
Site contact: Alison Rocchi · 614-685-0251 · Alison.Wandling@osumc.edu
Study contacts (from the official record)
- Alison Rocchi · 614-685-0251 · alison.wandling@osumc.edu
- Kristina Susi · 614-814-1277 · Kristina.Susi@osumc.edu
Similar studies in Ohio
All dermatology studies in Ohio →- RecruitingHealthy volunteersPhase 1
A 3-part Study of SYX-5219 in Healthy Volunteers and Participants With Atopic Dermatitis
Sitryx Therapeutics Ltd
- Location
- Boardman, OH + 5 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 2
An Open-Label Extension Study of ORKA-001 in Participants With Plaque Psoriasis
Oruka Therapeutics, Inc.
- Location
- Cleveland, OH + 22 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study to Evaluate the Safety and Effectiveness of Upadacitinib in Pediatric Participants With Alopecia Areata
AbbVie
- Location
- Fairborn, OH + 8 other US sites
- Eligibility basics
- Ages 6–17
- RecruitingPhase 2
A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
Apogee Therapeutics, Inc.
- Location
- Boardman, OH + 22 other US sites
- Eligibility basics
- Ages 18+